Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$522.38 +6.04 (+1.17%)
At close: Sep 24, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) EBT (2009 - 2026)

Vertex Pharmaceuticals (VRTX) posted EBT of $1.4 billion for Q2 2026, up 11.09% on a QoQ basis from $1.3 billion in Q1 2026, and up 8.48% year-over-year from $1.3 billion in Q2 2025.

Analysis

Vertex Pharmaceuticals (VRTX) EBT (2009 - 2026) Analysis & Trends

Vertex Pharmaceuticals has reported EBT for 18 years, with the latest figure at $1.4 billion in Q2 2026.

  • On a quarterly basis, EBT rose 8.48% year-over-year to $1.4 billion in Q2 2026; TTM through Jun 2026 was $5.3 billion, a 20.59% increase from a year earlier, with the FY2025 full-year figure at $4.6 billion, up 1768.49% from the prior year.
  • EBT was $1.4 billion for Q2 2026 at Vertex Pharmaceuticals, up from $1.3 billion in the prior quarter.
  • The five-year high for EBT was $1.4 billion in Q2 2026, with the low at -$3.4 billion in Q2 2024.
  • Average EBT over 5 years is $897.1 million, with a median of $1.2 billion recorded in 2022.
  • The sharpest annual moves came in 2022 and 2024: EBT soared 2417.65% in 2022, then sank 391.97% in 2024.
  • Over 5 years, EBT stood at $1.1 billion in 2022, then increased by 6.58% to $1.1 billion in 2023, then dropped by 0.97% to $1.1 billion in 2024, then advanced by 17.11% to $1.3 billion in 2025, then rose by 4.57% to $1.4 billion in 2026.
  • The last three EBT figures came in at $1.4 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 6.75 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 4.28 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -683.00 Mn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 4.27 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 2.80 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 2.77 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -10.25 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -653.00 Mn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 1.39 Bn
10 Bristol Myers Squibb 124.95 Bn 113.89 Bn 9.25 Bn 4.09 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.39 Bn
Mar 31, 2026 1.25 Bn
Dec 31, 2025 1.33 Bn
Sep 30, 2025 1.30 Bn
Jun 30, 2025 1.28 Bn
Mar 31, 2025 730.40 Mn
Dec 31, 2024 1.14 Bn
Sep 30, 2024 1.22 Bn
Jun 30, 2024 -3.39 Bn
Mar 31, 2024 1.28 Bn
Dec 31, 2023 1.15 Bn
Sep 30, 2023 1.18 Bn
Jun 30, 2023 1.16 Bn
Mar 31, 2023 891.50 Mn
Dec 31, 2022 1.08 Bn
Sep 30, 2022 1.18 Bn
Jun 30, 2022 1.02 Bn
Mar 31, 2022 954.80 Mn
Dec 31, 2021 870.90 Mn
Sep 30, 2021 1.08 Bn
API Access

Vertex Pharmaceuticals EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=VRTX&period=max&api_key=YOUR_API_KEY